[go: up one dir, main page]

FI964936L - Bentsopyraaneja ja niiden käyttö terapeuttisina aineina - Google Patents

Bentsopyraaneja ja niiden käyttö terapeuttisina aineina Download PDF

Info

Publication number
FI964936L
FI964936L FI964936A FI964936A FI964936L FI 964936 L FI964936 L FI 964936L FI 964936 A FI964936 A FI 964936A FI 964936 A FI964936 A FI 964936A FI 964936 L FI964936 L FI 964936L
Authority
FI
Finland
Prior art keywords
benzopyrans
therapeutic agents
therapeutic
agents
Prior art date
Application number
FI964936A
Other languages
English (en)
Swedish (sv)
Other versions
FI964936A0 (fi
FI120686B (fi
Inventor
Wai Ngor Chan
Helen Kate Ann Morgan
Mervyn Thompson
John Morris Evans
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9411632A external-priority patent/GB9411632D0/en
Priority claimed from GB9411798A external-priority patent/GB9411798D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FI964936A0 publication Critical patent/FI964936A0/fi
Publication of FI964936L publication Critical patent/FI964936L/fi
Application granted granted Critical
Publication of FI120686B publication Critical patent/FI120686B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
FI964936A 1994-06-10 1996-12-10 Bentsopyraanit ja niiden käyttö terapeuttisina aineina FI120686B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9411632 1994-06-10
GB9411632A GB9411632D0 (en) 1994-06-10 1994-06-10 Novel treatment
GB9411798 1994-06-13
GB9411798A GB9411798D0 (en) 1994-06-13 1994-06-13 Novel treatment
PCT/EP1995/002076 WO1995034545A1 (en) 1994-06-10 1995-05-31 Benzopyrans and their use as therapeutic agents
EP9502076 1995-05-31

Publications (3)

Publication Number Publication Date
FI964936A0 FI964936A0 (fi) 1996-12-10
FI964936L true FI964936L (fi) 1997-02-06
FI120686B FI120686B (fi) 2010-01-29

Family

ID=26305044

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964936A FI120686B (fi) 1994-06-10 1996-12-10 Bentsopyraanit ja niiden käyttö terapeuttisina aineina

Country Status (29)

Country Link
US (1) US5760074A (fi)
EP (2) EP0764157B1 (fi)
JP (2) JP3575767B2 (fi)
KR (1) KR100397721B1 (fi)
CN (2) CN1174975C (fi)
AP (1) AP714A (fi)
AT (2) ATE250052T1 (fi)
AU (1) AU701060B2 (fi)
BG (1) BG63339B1 (fi)
BR (1) BR9507980A (fi)
CA (1) CA2192480C (fi)
CY (1) CY2508B1 (fi)
CZ (1) CZ286081B6 (fi)
DE (2) DE69524871T2 (fi)
DK (2) DK1114821T3 (fi)
ES (2) ES2207590T3 (fi)
FI (1) FI120686B (fi)
HK (2) HK1001286A1 (fi)
HU (1) HUT76136A (fi)
NO (1) NO315651B1 (fi)
NZ (1) NZ287872A (fi)
OA (1) OA10593A (fi)
PL (1) PL188134B1 (fi)
PT (2) PT764157E (fi)
RO (1) RO113463B1 (fi)
SG (1) SG67930A1 (fi)
SI (2) SI0764157T1 (fi)
SK (1) SK281456B6 (fi)
WO (1) WO1995034545A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021780A1 (en) * 1992-12-11 2001-09-13 Smithkline Beecham P.L.C. Pharmaceutical composition containing bicyclic type compounds
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
GB9619492D0 (en) * 1996-09-18 1996-10-30 Smithkline Beecham Plc Novel treatment
US6492415B2 (en) * 1996-09-18 2002-12-10 Smithkline Beecham P.L.C. Use of benzopyranols to treat neurological disorders
GB9726543D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel compositions
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
GB0028697D0 (en) * 2000-11-23 2001-01-10 S P A Novel process
BRPI0607684A2 (pt) * 2005-04-04 2009-09-22 Takeda Pharmaceutical composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida
CA2726874A1 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
EP2307004A1 (en) * 2008-06-05 2011-04-13 Minster Research Limited Novel treatments
CN102770134A (zh) 2009-12-03 2012-11-07 普罗克西梅根有限公司 传染性失调的治疗
CA2782625A1 (en) * 2009-12-03 2011-06-09 Proximagen Ltd Treatment of allodynia and hyperalgesia
EP2870148A1 (en) 2012-07-03 2015-05-13 Proximagen Limited Pro-drug compounds
GB201304814D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Pro-drug compounds
GB201322932D0 (en) * 2013-12-23 2014-02-12 Proximagen Ltd Pro-drug compounds
GB201322934D0 (en) 2013-12-23 2014-02-12 Proximagen Ltd Prodrug compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
KR100326968B1 (ko) * 1992-12-11 2002-07-27 스미스클라인비이참피이엘시이 약학적 활성을 가진 이환식 화합물
ES2143541T3 (es) * 1992-12-11 2000-05-16 Smithkline Beecham Plc Composicion farmaceutica que contiene compuestos de tipo biciclico.
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
FI964936A0 (fi) 1996-12-10
JPH10501251A (ja) 1998-02-03
ES2207590T3 (es) 2004-06-01
NO965260L (no) 1997-02-06
DE69524871T2 (de) 2002-08-22
CN1336369A (zh) 2002-02-20
ATE211469T1 (de) 2002-01-15
NZ287872A (en) 1998-05-27
CN1154698A (zh) 1997-07-16
PT1114821E (pt) 2004-02-27
US5760074A (en) 1998-06-02
DE69531801T2 (de) 2004-07-01
HU9603415D0 (en) 1997-02-28
HUT76136A (en) 1997-06-30
KR100397721B1 (ko) 2004-04-28
RO113463B1 (ro) 1998-07-30
HK1039115B (zh) 2004-08-13
CN1234702C (zh) 2006-01-04
SK158796A3 (en) 1997-07-09
ES2170798T3 (es) 2002-08-16
AP9600889A0 (en) 1997-01-31
JP2003238554A (ja) 2003-08-27
EP1114821A1 (en) 2001-07-11
AP714A (en) 1998-12-23
AU2672795A (en) 1996-01-05
NO965260D0 (no) 1996-12-09
HK1039115A1 (en) 2002-04-12
SG67930A1 (en) 1999-10-19
EP0764157B1 (en) 2002-01-02
BG101040A (en) 1997-08-29
PL188134B1 (pl) 2004-12-31
AU701060B2 (en) 1999-01-21
DE69531801D1 (de) 2003-10-23
ATE250052T1 (de) 2003-10-15
JP3575767B2 (ja) 2004-10-13
WO1995034545A1 (en) 1995-12-21
OA10593A (en) 2002-07-10
PT764157E (pt) 2002-06-28
SK281456B6 (sk) 2001-03-12
BR9507980A (pt) 1997-08-12
SI0764157T1 (en) 2002-06-30
CA2192480C (en) 2007-07-24
DE69524871D1 (de) 2002-02-07
CY2508B1 (en) 2005-12-23
CZ286081B6 (cs) 2000-01-12
DK0764157T3 (da) 2002-04-22
DK1114821T3 (da) 2004-02-02
FI120686B (fi) 2010-01-29
EP1114821B1 (en) 2003-09-17
HK1001286A1 (en) 1998-06-12
BG63339B1 (bg) 2001-10-31
CZ361796A3 (en) 1997-08-13
CA2192480A1 (en) 1995-12-21
CN1174975C (zh) 2004-11-10
EP0764157A1 (en) 1997-03-26
NO315651B1 (no) 2003-10-06
PL317579A1 (en) 1997-04-14
SI1114821T1 (en) 2004-02-29

Similar Documents

Publication Publication Date Title
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI955051A0 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI971412L (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä
FI970762L (fi) Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet
FI945625L (fi) Indolokarbatsoli-imidit ja niiden käyttö
NO992806D0 (no) Terapeutiske midler
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
ID18679A (id) Penggunaan terapi lanjutan
FI964936L (fi) Bentsopyraaneja ja niiden käyttö terapeuttisina aineina
FI951060L (fi) Formulaatioita ja hoitomenetelmiä
FI964482L (fi) Amidijohdannaisia ja niiden käyttö lääkkeenä
BR9509688A (pt) Composto e composição farmacêutica
FI971364L (fi) Kolkisiinijohdannaiset ja niiden terapeuttinen käyttö
DE4494231T1 (de) Therapeutische Zusammensetzung und ihre Anwendung
FI963130L (fi) Heterosykliset yhdisteet sekä niiden valmistus ja käyttö
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
FI964854L (fi) Hydroksitioasetamidien valmistus ja niiden käyttö bentsotiofeenien synteesissä
FI942265L (fi) 2-aminopyratsin-5-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
BR9505130A (pt) Composto e composiçao farmacêutica
ATA155395A (de) Funktionelle lumbalbandage
ZA954732B (en) Benzopyrans and their use as therapeutic agents
FI951762A0 (fi) Substituoituja morfoliinijohdannaisia ja niiden käyttö terapeuttisina aineina
BR9304388A (pt) Composição terapêutica de uso nasal

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120686

Country of ref document: FI

MA Patent expired